EGF and breast carcinoma: Since EGF is a MAPK regulatory target that plays a significant role in breast cancer progression and exhibited the largest changes in our RNA-seq and secretome analyses, we evaluated whether MAPK pathway activation and EGF stimulation were sufficient to induce stem cells to transdifferentiate or replicate from in vivo breast cancer cell transplants.